Green Cross Health (GXH) H1 2026 earnings summary

Executive summary

• Operating revenue for the six months ended 30 September 2025 was $264.4m, up 2% year-over-year.

• Net profit after tax increased to $9.1m from $8.1m in the prior year period, while net profit attributable to shareholders was $7.2m, up 27%.

• Basic earnings per share rose to 5.00 cents from 3.93 cents year-over-year.

• Operating profit before interest and tax was $17.5m, up 9% year-over-year.

• Approval received to commence operations as a Primary Health Organisation from 1 July 2026.

Financial highlights

• Interim dividend of 3.00 cents per share declared, payable in December 2025.

• Pharmacy Division revenue was $181.7m; Medical Division revenue grew 6% to $82.7m.

• Pharmacy Division operating profit declined 14% to $7.7m; Medical Division operating profit increased 42% to $11.6m.

• Cash and cash equivalents at period end were $23.7m, down from $28.9m a year earlier.

• Net cash inflow from operating activities was $21.6m, compared to $25.3m in the prior year.

Outlook and guidance

• Focus on preparing for Primary Health Organisation launch in July 2026.

• Continued investment in technology, refurbishments, and cost management across divisions.

• Board remains cautiously optimistic about New Zealand's economic recovery and retail outlook for 2026.

• An interim dividend of 3.00 cents per share was declared, fully imputed, to be paid in December 2025.